Dipòsit Digital de la Universitat de Barcelonametadata only
Efficacy and safety of plasma exchange with 5% albumin to modify cerebrospinal fluid and plasma amyloid-β concentrations and cognition outcomes in Alzheimer's disease patients: a multicenter, randomized, controlled clinical trial
albúmines, ús terapèutic, pèptids, sang, líquid cefalorraquidi, trastorns de la cognició, albumins, therapeutic use
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 184978
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.